Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Rossella Loria, Giulia Bon, Valentina Perotti, Enzo Gallo, Ilaria Bersani, Paola Baldassari, Manuela Porru, Carlo Leonetti, Selene Di Carlo, Paolo Visca, Maria Felice Brizzi, Andrea Anichini, Roberta Mortarini, Rita Falcioni
Published Dec 18, 2014 · Vol. 6, No. 5 · pp. 2779-2793
Gerwin Heller, Corinna Altenberger, Bianca Schmid, Maximilian Marhold, Erwin Tomasich, Barbara Ziegler, Leonhard Müllauer, Christoph Minichsdorfer, György Lang, Adelheid End-Pfützenreuter, Balazs Döme, Britt-Madeleine Arns, Kwun M. Fong, Casey M. Wright, Ian A. Yang, Walter Klepetko, Christoph C. Zielinski, Sabine Zöchbauer-Müller
Published Dec 5, 2014 · Vol. 6, No. 1 · pp. 394-408
Keywords: DNA methylation, microarray analysis, ZNF677, MS-HRM analysis, non-small cell lung cancer